The Asia Pacific Head And Neck Cancer Therapeutics Market would witness market growth of 13.4% CAGR during the forecast period (2022-2028).
Head and neck cancers often develop in the squamous cells lining the head and neck's mucosal surfaces for example, those inside the mouth, throat, and voice box. These tumors are referred to as head and neck squamous cell carcinomas. In addition to squamous cell carcinomas, head and neck cancers can arise in the salivary glands, sinuses, muscles, or nerves of the head and neck, although these tumors are far less prevalent.
Head and neck cancer can form in the Oral cavity including the lips, the front two-thirds of the tongue, the gums, the lining of the cheeks and lips, the floor of the mouth under the tongue, the hard palate (bony top of the mouth), and the little patch of gum behind the wisdom teeth. The pharynx is a cylinder approximately 5 inches long that begins below the nose and connects to the esophagus.
In addition, the epiglottis is a little patch of tissue that covers the voice box to keep food from reaching the airways. The paranasal sinuses and nasal cavities are tiny cavities inside the skull bones around the nose and the nasal cavity is the cavity within the nose. The primary salivary glands are located near the jawbone on the surface of the mouth's floor. Salivary glands generate saliva. Small salivary glands are distributed throughout the mouth and throat's mucous membranes.
In the past 15 years, HNC risk factor trends have altered substantially. Due to a lack of awareness and the late discovery of cancer in its advanced stages, nearly half of all diagnosed cases are deemed fatal. HNC is the third most prevalent cancer in India, accounting for 52 067 fatalities and 77 000 cases in 2012. Many instances of HNC go untreated or unreported, the true incidence is substantially higher than the estimates. Numerous studies demonstrate that risk variables are not only etiological drivers of HNC but are also associated with an elevated prevalence risk of HNC. In addition to HPV, alcohol intake and cigarette use be the major risk factors for head and neck cancer (HNC).
The China market dominated the Asia Pacific Head & Neck Cancer Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $176.9 Million by 2028. The Japan market is estimated to grow a CAGR of 12.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 14.1% during (2022 - 2028).
Based on Therapy Type, the market is segmented into Immunotherapy, Chemotherapy, and Targeted Therapy. Based on Route of Administration, the market is segmented into Injectable and Oral. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Head And Neck Cancer Therapeutics Market is Projected to reach USD 2.5 Billion by 2028, at a CAGR of 12.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Bristol Myers Squibb Company, and Clinigen Group PLC.
Scope of the Study
Market Segments Covered in the Report:
By Therapy Type
- Immunotherapy
- Chemotherapy
- Targeted Therapy
By Route of Administration
By Distribution Channel
- Retail & Specialty Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Eli Lilly and Company
- Merck & Co., Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceuticals Industries Ltd.
- F. Hoffmann-La Roche Ltd.
- AstraZeneca Plc
- Bristol Myers Squibb Company
- Clinigen Group PLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Head & Neck Cancer Therapeutics Market, by Therapy Type
1.4.2 Asia Pacific Head & Neck Cancer Therapeutics Market, by Route of Administration
1.4.3 Asia Pacific Head & Neck Cancer Therapeutics Market, by Distribution Channel
1.4.4 Asia Pacific Head & Neck Cancer Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Head And Neck Cancer Therapeutics Market
Chapter 4. Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type
4.1 Asia Pacific Immunotherapy Market by Country
4.2 Asia Pacific Chemotherapy Market by Country
4.3 Asia Pacific Targeted Therapy Market by Country
Chapter 5. Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration
5.1 Asia Pacific Injectable Market by Country
5.2 Asia Pacific Oral Market by Country
Chapter 6. Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel
6.1 Asia Pacific Retail & Specialty Pharmacies Market by Country
6.2 Asia Pacific Hospital Pharmacies Market by Country
6.3 Asia Pacific Online Pharmacies Market by Country
Chapter 7. Asia Pacific Head & Neck Cancer Therapeutics Market by Country
7.1 China Head & Neck Cancer Therapeutics Market
7.1.1 China Head & Neck Cancer Therapeutics Market by Therapy Type
7.1.2 China Head & Neck Cancer Therapeutics Market by Route of Administration
7.1.3 China Head & Neck Cancer Therapeutics Market by Distribution Channel
7.2 Japan Head & Neck Cancer Therapeutics Market
7.2.1 Japan Head & Neck Cancer Therapeutics Market by Therapy Type
7.2.2 Japan Head & Neck Cancer Therapeutics Market by Route of Administration
7.2.3 Japan Head & Neck Cancer Therapeutics Market by Distribution Channel
7.3 India Head & Neck Cancer Therapeutics Market
7.3.1 India Head & Neck Cancer Therapeutics Market by Therapy Type
7.3.2 India Head & Neck Cancer Therapeutics Market by Route of Administration
7.3.3 India Head & Neck Cancer Therapeutics Market by Distribution Channel
7.4 South Korea Head & Neck Cancer Therapeutics Market
7.4.1 South Korea Head & Neck Cancer Therapeutics Market by Therapy Type
7.4.2 South Korea Head & Neck Cancer Therapeutics Market by Route of Administration
7.4.3 South Korea Head & Neck Cancer Therapeutics Market by Distribution Channel
7.5 Singapore Head & Neck Cancer Therapeutics Market
7.5.1 Singapore Head & Neck Cancer Therapeutics Market by Therapy Type
7.5.2 Singapore Head & Neck Cancer Therapeutics Market by Route of Administration
7.5.3 Singapore Head & Neck Cancer Therapeutics Market by Distribution Channel
7.6 Malaysia Head & Neck Cancer Therapeutics Market
7.6.1 Malaysia Head & Neck Cancer Therapeutics Market by Therapy Type
7.6.2 Malaysia Head & Neck Cancer Therapeutics Market by Route of Administration
7.6.3 Malaysia Head & Neck Cancer Therapeutics Market by Distribution Channel
7.7 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market
7.7.1 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type
7.7.2 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration
7.7.3 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Eli Lilly And Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.2 Merck & Co., Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Takeda Pharmaceutical Company Limited
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Geographical Expansions:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 F. Hoffmann-La Roche Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Bristol Myers Squibb Company
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Clinigen Group PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
TABLE 1 Asia Pacific Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Immunotherapy Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Immunotherapy Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Chemotherapy Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Chemotherapy Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Targeted Therapy Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Targeted Therapy Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Retail & Specialty Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Head & Neck Cancer Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Head & Neck Cancer Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 27 China Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 28 China Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 29 China Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 30 China Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 31 China Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 32 China Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 33 China Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 34 China Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 35 Japan Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 36 Japan Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 37 Japan Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 38 Japan Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 39 Japan Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 40 Japan Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 41 Japan Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 Japan Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 India Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 44 India Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 45 India Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 46 India Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 47 India Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 48 India Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 49 India Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 50 India Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 51 South Korea Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 52 South Korea Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 53 South Korea Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 54 South Korea Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 55 South Korea Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 56 South Korea Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 57 South Korea Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 58 South Korea Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 59 Singapore Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 60 Singapore Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 61 Singapore Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 62 Singapore Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 63 Singapore Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 64 Singapore Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 65 Singapore Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 Singapore Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 Malaysia Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 68 Malaysia Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 69 Malaysia Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 70 Malaysia Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 71 Malaysia Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 72 Malaysia Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 73 Malaysia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 74 Malaysia Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 75 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market, 2018 - 2021, USD Million
TABLE 76 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market, 2022 - 2028, USD Million
TABLE 77 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2018 - 2021, USD Million
TABLE 78 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Therapy Type, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Head & Neck Cancer Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 83 Key Information – Eli Lilly And Company
TABLE 84 KEY INFORMATION - MERCK & CO., INC.
TABLE 85 Key Information – Sanofi S.A.
TABLE 86 Key Information – Takeda Pharmaceutical Company Limited
TABLE 87 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 88 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 89 KEY INFORMATION – AstraZeneca PLC
TABLE 90 Key Information – Bristol Myers Squibb Company
TABLE 91 Key Information – Clinigen Group PLC
List of Figures
FIG 1 Methodology for the research